Pacer Advisors
BEAM icon

Pacer Advisors’s Beam Therapeutics BEAM Stock Holding History

Pacer Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54K Buy
+1,563
New +$47.2K ﹤0.01% 2018
2024
Q3 		– Sell
-940
Closed -$22K – 2579
2024
Q2 		$22K Sell
940
-194
-17% -$4.76K ﹤0.01% 3408
2024
Q1 		$37.5K Buy
+1,134
New +$35.3K ﹤0.01% 3287
2021
Q2 		– Sell
-791
Closed -$63K – 1426
2021
Q1 		$63K Sell
791
-742
-48% -$70.6K ﹤0.01% 1409
2020
Q4 		$125K Buy
+1,533
New +$75.4K ﹤0.01% 1328

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Pacer Advisors's BEAM Position: Q2 2026 in Review

Pacer Advisors opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 1,563 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #2018 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in BEAM as recently as Q2 2024.

Pacer Advisors first reported a position in BEAM in Q4 2020 and has held it in 5 quarters since. The position peaked at $125K in Q4 2020. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Pacer Advisors held 1,563 shares of Beam Therapeutics worth $54K as of Q2 2026.
  • Beam Therapeutics was a new Pacer Advisors position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2018 holding.
  • Pacer Advisors first reported a position in Beam Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • Pacer Advisors's Beam Therapeutics position peaked at $125K in Q4 2020.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.